China NMPA Product Recall - Integrated membrane oxygenator, arterial filter, and venous blood storage device

Maikewei (Shanghai) Medical Equipment Co., Ltd. has initiated a voluntary Class II recall for specific medical devices, including integrated membrane oxygenators, arterial filters, and venous blood storage devices. This action, reported by the National Medical Products Administration (NMPA) on October 29, 2018, addresses a critical product defect. The primary issue identified is leakage at the blood inlet of certain models, which could compromise the devices' intended function. Such malfunction poses potential safety risks for patients undergoing medical procedures where these devices are used. The recall falls under the regulatory oversight of the NMPA, highlighting China's framework for ensuring medical device safety. While specific inspection dates are not provided, the recall publication date marks the official announcement of the issue and the company's response. Maikewei (Shanghai) Medical Equipment Co., Ltd. is required to undertake comprehensive actions to identify, retrieve, and manage all affected products in circulation. This includes notifying relevant healthcare facilities and distributors to ensure the safe removal of the faulty devices from use. The Class II classification indicates that the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. This proactive measure aims to mitigate potential patient harm and maintain public trust in medical equipment safety standards.